Price $70.51 |
Market Cap
97.91B
|
Sector Health Care |
Div. Growth
37.60%
|
|
P/E
23.7
|
P/B
-
|
P/S
2.98
|
Dividend %
6.50%
|
|
P/CF
63.7
|
P/FCF
14.7
|
Op. Cash Flow
13.41M
|
FCF
4.4
|
|
Op. Margin
21.80%
|
Net Margin
12.50%
|
ROE
-58.90%
|
ROI
21.80%
|
|
ROA
6.80%
|
EPS Growth
-32.70%
|
Current Ratio
1.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.27 | - | - | 11.6M | Strong Buy |
| Streamline Health Solutions In (STRM) | $1.23 | - | - | 29.5M | Strong Buy |
| Assertio Therapeutics Inc (ASRT) | $1.36 | - | - | 94.6M | Strong Buy |
| Natus Medical Inc (NTUS) | $31.00 | - | - | 954.3M | Strong Buy |
| Bausch Health Companies Inc (BHC) | $23.24 | - | - | 7.58B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
